T1	Pharmacological_substance 0 10	Rocuronium
N1000 	Reference T1 MeSH:C061870	Rocuronium
T2	Disorder 101 132	pseudocholinesterase deficiency
N1 	Reference T2 UMLS:C0268379	pseudocholinesterase deficiency
T4	Disorder 188 211	catatonic schizophrenia
N2 	Reference T4 UMLS:C0036344	catatonic schizophrenia
T5	Disorder 216 247	pseudocholinesterase deficiency
N3 	Reference T5 UMLS:C0268379	pseudocholinesterase deficiency
T7	Pharmacological_substance 259 302	nondepolarizing neuromuscular blocking drug
T8	Pharmacological_substance 304 314	rocuronium
N1001 	Reference T8 MeSH:C061870	rocuronium
T9	Pharmacological_substance 421 431	Rocuronium
N1002 	Reference T9 MeSH:C061870	Rocuronium
T10	Pharmacological_substance 568 583	succinylcholine
N1003 	Reference T10 MeSH:D013390	succinylcholine
T3	Pharmacological_substance 26 36	sugammadex
N1004 	Reference T3 MeSH:C453980	sugammadex
T6	Subject 86 95	a patient
T11	Pharmacological_substance 357 367	sugammadex
N1005 	Reference T11 MeSH:C453980	sugammadex
T12	Pharmacological_substance 436 446	sugammadex
N1006 	Reference T12 MeSH:C453980	sugammadex
T13	Subject 173 182	a patient
T14	Pharmacological_substance 332 355	specific reversal agent
T16	Combination 432 435	and
